Cowen analyst Phil Nadeau downgraded Biogen (NASDAQ: BIIB) from Outperform to Market Perform with a price target of $215.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades Hot Comments Hot Downgrades

Biogen (BIIB) PT Lowered to $338 at Wells FargoNovember 9, 2020 5:50 AM Stocks expected to have increasing option volume: BIIB ACB TLRY CRON HEXO November 9, 2020 5:26 AM Biogen (BIIB) IV elevated into results of FDA advisory committee votingNovember 9, 2020 4:53 AM Biogen (BIIB) IV elevated into results of FDA advisory committee votingNovember 9, 2020 4:40 AM Biogen (BIIB) PT Lowered to $382 at SVB LeerinkNovember 9, 2020 4:39 AM Atlantic Equities Downgrades Biogen (BIIB) to UnderweightNovember 9, 2020 3:47 AM Form 4 BIOGEN INC. For: Nov 04 Filed by: Sandrock AlfredNovember 6, 2020 9:40 PM Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s DiseaseNovember 6, 2020 8:15 PM Biogen (BIIB) IV into FDA panel to discuss Biogen Alzheimer's application and voteNovember 6, 2020 7:50 PM Biotech ETF (IBB) Lower After Biogen (BIIB) FDA Panel Negative Vote on Question 1November 6, 2020 3:23 PM Biogen (BIIB) Study Fails to Show Alzheimer's Effectiveness, Says FDA PanelNovember 6, 2020 3:19 PM Biogen (BIIB) Halted, News PendingNovember 6, 2020 6:56 AM Stocks expected to have increasing option volume: NET UBER BMY ZTS BIIB MTCHNovember 6, 2020 4:34 AM Biogen (BIIB) option implied volatility elevated after sharp rally into FDA panelNovember 5, 2020 10:44 AM Increasing unusual put option volume: WMGI BKLN RSX MTCH ZNGA ELAN XME KKR BIIB WENNovember 5, 2020 4:22 AM Stocks with Implied Volatility MovementNovember 5, 2020 4:15 AM Biogen (BIIB) PT Raised to $402 at SVB LeerinkNovember 5, 2020 4:12 AM